{
  "kind": "framework",
  "value": "pipeline-table",
  "collectionKey": "slides:framework:pipeline-table:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 3,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de076-4a3e-76ed-83f8-e348223f91d9",
      "docSlug": "c1eecdcf261eded4e99ffa840c30e475",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 60 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The slide uses a standard pharmaceutical pipeline table format, categorizing assets by clinical vs. preclinical status and highlighting specific clinical trial results and regulatory designations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Standard industry format for displaying drug development stages",
      "slideHref": "/slides/019de076-4a3e-76ed-83f8-e348223f91d9/27",
      "deckHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9",
      "deckAnchorHref": "/decks/019de076-4a3e-76ed-83f8-e348223f91d9#slide-27",
      "loopMatches": [
        {
          "to": 60,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "50c25ad2-0c48-4213-947d-b362da490be1",
          "evidence": "The deck presents a 'why' (N-GENIUS platform), 'how' (technology overview), and 'what' (clinical results) narrative",
          "position": 1,
          "objective": "Why is Immix Biopharma's N-GENIUS platform important?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 34,
          "from": 18,
          "beatId": "59dea3e4-911d-4dc4-b5bf-44d94b3ffdaf",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 18-34: Various traction slides",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5fec-763b-95cd-961b6879cda6",
      "docSlug": "njj0K6xhOdjDOAwq28MP",
      "documentTitle": "See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech",
      "authorId": "Pitchdecks",
      "authorName": "Moderna",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.29,
      "pageNumber": 20,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The slide uses a tabular format to track clinical progress across different therapeutic areas (Viral Vaccines, Immuno-Oncology, CV).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Standard industry format for tracking drug development stages.",
      "slideHref": "/slides/019dd923-5fec-763b-95cd-961b6879cda6/20",
      "deckHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6",
      "deckAnchorHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 14,
          "beatId": "c1aedf83-4c3e-4212-855e-0f80dab7b8c9",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Roadmap",
          "beatSlug": null,
          "evidence": "The presentation outlines Moderna's pipeline and future plans.",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019dd923-5fec-763b-95cd-961b6879cda6",
      "docSlug": "njj0K6xhOdjDOAwq28MP",
      "documentTitle": "See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech",
      "authorId": "Pitchdecks",
      "authorName": "Moderna",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "strategy_consulting",
      "sourceTypeLabel": "Strategy consulting",
      "presentationDate": null,
      "orientation": "landscape",
      "aspectRatio": 1.29,
      "pageNumber": 23,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a standard pharmaceutical pipeline table format.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Standard industry format for tracking drug development stages",
      "slideHref": "/slides/019dd923-5fec-763b-95cd-961b6879cda6/23",
      "deckHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6",
      "deckAnchorHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}